Cargando…

A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis

Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease. In the present retrospective study, we aimed to investigate coagulation disorders and their outcome implications in patients with secondary HLH. We evaluated clinical characteristics and the relationship between coagul...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shixuan, Lv, Kebing, Zhou, Yulan, Cheng, Xiaoye, Chen, Zhiwei, Shen, Huimin, Li, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567857/
https://www.ncbi.nlm.nih.gov/pubmed/37561154
http://dx.doi.org/10.1007/s00277-023-05398-w
_version_ 1785119228892807168
author Wang, Shixuan
Lv, Kebing
Zhou, Yulan
Cheng, Xiaoye
Chen, Zhiwei
Shen, Huimin
Li, Fei
author_facet Wang, Shixuan
Lv, Kebing
Zhou, Yulan
Cheng, Xiaoye
Chen, Zhiwei
Shen, Huimin
Li, Fei
author_sort Wang, Shixuan
collection PubMed
description Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease. In the present retrospective study, we aimed to investigate coagulation disorders and their outcome implications in patients with secondary HLH. We evaluated clinical characteristics and the relationship between coagulation indices and prognosis in HLH patients (n = 141). The information, including clinical symptoms, laboratory indicators, and coagulation indices, was evaluated. Coagulation disorders and bleeding events occurred in 95 (67.4%) and 60 (42.6%) patients, respectively. A coagulation index analysis primarily showed elevated levels of D-Dimer, the international standardized ratio (INR), prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT), while the prothrombin activity, fibrinogen levels, and platelet levels were significantly decreased. Dominant disseminated intravascular coagulation (DIC) occurred in 76 patients (53.9%). Patients with lymphoma-associated hemophagocytic syndrome (LAHS) frequently exhibited apparent coagulation disorders. Multivariate analysis revealed that age ≥ 29.5 years, bleeding events, APTT ≥ 47.3 s, fibrinogen ≤ 1.68 g/L, and absolute neutrophil counts (ANC) of ≤ 1.21 × 10(9)/L were independent prognostic factors. We thereby devised a prognostic scoring system and stratified patients into low-risk (0–2 points), intermediate-risk (3–4 points), and high-risk (5–7 points) groups, and the 1-year overall survival rates in the above-mentioned groups were 66.40%, 40.00%, and 2.30%, respectively (P < 0.0001). In conclusion, coagulation dysfunctions and bleeding tendencies were common characteristics in HLH patients. We constructed a novel prognostic score model based on APTT, fibrinogen level, ANC, age, and bleeding events, which had superior prognostic value compared with these markers alone. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00277-023-05398-w.
format Online
Article
Text
id pubmed-10567857
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-105678572023-10-13 A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis Wang, Shixuan Lv, Kebing Zhou, Yulan Cheng, Xiaoye Chen, Zhiwei Shen, Huimin Li, Fei Ann Hematol Original Article Secondary hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease. In the present retrospective study, we aimed to investigate coagulation disorders and their outcome implications in patients with secondary HLH. We evaluated clinical characteristics and the relationship between coagulation indices and prognosis in HLH patients (n = 141). The information, including clinical symptoms, laboratory indicators, and coagulation indices, was evaluated. Coagulation disorders and bleeding events occurred in 95 (67.4%) and 60 (42.6%) patients, respectively. A coagulation index analysis primarily showed elevated levels of D-Dimer, the international standardized ratio (INR), prothrombin time (PT), activated partial thromboplastin time (APTT), and thrombin time (TT), while the prothrombin activity, fibrinogen levels, and platelet levels were significantly decreased. Dominant disseminated intravascular coagulation (DIC) occurred in 76 patients (53.9%). Patients with lymphoma-associated hemophagocytic syndrome (LAHS) frequently exhibited apparent coagulation disorders. Multivariate analysis revealed that age ≥ 29.5 years, bleeding events, APTT ≥ 47.3 s, fibrinogen ≤ 1.68 g/L, and absolute neutrophil counts (ANC) of ≤ 1.21 × 10(9)/L were independent prognostic factors. We thereby devised a prognostic scoring system and stratified patients into low-risk (0–2 points), intermediate-risk (3–4 points), and high-risk (5–7 points) groups, and the 1-year overall survival rates in the above-mentioned groups were 66.40%, 40.00%, and 2.30%, respectively (P < 0.0001). In conclusion, coagulation dysfunctions and bleeding tendencies were common characteristics in HLH patients. We constructed a novel prognostic score model based on APTT, fibrinogen level, ANC, age, and bleeding events, which had superior prognostic value compared with these markers alone. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00277-023-05398-w. Springer Berlin Heidelberg 2023-08-10 2023 /pmc/articles/PMC10567857/ /pubmed/37561154 http://dx.doi.org/10.1007/s00277-023-05398-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Wang, Shixuan
Lv, Kebing
Zhou, Yulan
Cheng, Xiaoye
Chen, Zhiwei
Shen, Huimin
Li, Fei
A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
title A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
title_full A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
title_fullStr A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
title_full_unstemmed A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
title_short A novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
title_sort novel prognosis-prediction model based on coagulation indicators in secondary hemophagocytic lymphohistiocytosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567857/
https://www.ncbi.nlm.nih.gov/pubmed/37561154
http://dx.doi.org/10.1007/s00277-023-05398-w
work_keys_str_mv AT wangshixuan anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT lvkebing anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT zhouyulan anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT chengxiaoye anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT chenzhiwei anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT shenhuimin anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT lifei anovelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT wangshixuan novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT lvkebing novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT zhouyulan novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT chengxiaoye novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT chenzhiwei novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT shenhuimin novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis
AT lifei novelprognosispredictionmodelbasedoncoagulationindicatorsinsecondaryhemophagocyticlymphohistiocytosis